LH — Labcorp Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Labcorp Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,557	2,380	1,281	419	747
Depreciation
Deferred Taxes
Non-Cash Items	858	325	627	771	369
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-857	-264	-603	-362	-154
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	2,135	3,110	1,956	1,328	1,586
Capital Expenditures	-382	-460	-482	-454	-490
Purchase of Fixed Assets
Other Investing Cash Flow Items	-262	-424	-1,170	-718	-877
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-643	-885	-1,652	-1,172	-1,367
Financing Cash Flow Items	-61.1	-74	-77.6	1,440	217
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-517	-2,066	-1,322	-59.3	780
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	983	152	-1,043	107	982